1 |
Zhu S, Ma AH, Zhu Z, Adib E, Rao T, Li N, Ni K, Chittepu VCSR, Prabhala R, Garisto Risco J, Kwiatkowski D, Mouw K, Sonpavde G, Cheng F, Pan CX. Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer. J Immunother Cancer 2021;9:e002917. [PMID: 34725212 DOI: 10.1136/jitc-2021-002917] [Reference Citation Analysis]
|
2 |
Li P, Che S, Qi Y, Luo N, Lin Q, Zhu X, Xuan Y, Li M, Li J, Ge M, Sun T, Qi C, Wang Y. Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma. J Cancer Res Clin Oncol 2022. [PMID: 35838838 DOI: 10.1007/s00432-022-04195-8] [Reference Citation Analysis]
|